Most Recent

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

image: Generating Cardiac Precursor Cells

Generating Cardiac Precursor Cells

By | June 1, 2016

Researchers derive cardiac precursors to form cardiac muscle, endothelial, and smooth muscle cells in mice.

0 Comments

image: Myriad, Post Mortem

Myriad, Post Mortem

By | June 1, 2016

David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.

0 Comments

image: The Fatty Acid–Ketone Switch

The Fatty Acid–Ketone Switch

By | June 1, 2016

In failing hearts, cardiomyocytes change their fuel preference.

1 Comment

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: In Failing Hearts, Cardiomyocytes Alter Metabolism

In Failing Hearts, Cardiomyocytes Alter Metabolism

By | June 1, 2016

While the heart cells normally burn fatty acids, when things go wrong ketones become the preferred fuel source.

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

image: Editing Genomes to Record Cellular Histories

Editing Genomes to Record Cellular Histories

By | May 26, 2016

Researchers harness the power of genome editing to track cell lineages throughout zebrafish development.

0 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech